Pliant Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$1.13

+0.02 (+1.35%)

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 6 60%

Sell 4 40%

Price Target

Analyst Price Target +1,418.2% upside

Low Target $13.48

Average Target $17.08

High Target $25.30

Current Price $1.13

Current
$1.13

Target
$17.08

$13.48 $17.08 avg $25.30

Scenario Analysis

Bear Case

$13.48

1,098.2%

Low target

Base Case

$17.08

+1,418.2%

Avg target

Bull Case

$25.30

+2,148.9%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$1.95

-42.3% from high

52-Week Low

$1.02

+10.3% from low

Target vs 52W High

$17.08

+775.9% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+14.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.2%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+6.5%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+22.2%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+178.7%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-38.0%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+194.2%